In addition, we could demonstrate that our corresponding cascade brominations were also compatible with more complex starting materials. For instance, the pharmaceutical molecules aminoglutethimide, Lenalidomide and benzodioxepin-amine showed excellent reactivity in the electrochemical bromination cascade, providing products 175-178 in 42-85% yield, when using a current of 15 mA. Gratifyingly, it also proved possible to start from carboxylic acids with this chemistry, as shown by the reactions involving precursors of Regorafenib and Ibuprofen, which afforded the brominated product 179-181 product in 30-48% yield. Overall the results summarized in Scheme 7, clearly demonstrate the high synthetic utility of the developed acylation/C-H halogenation cascade protocols for accessing both known pharmaceutical compounds as well as completely new analogues whose biological activity could be interesting to study further.